Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Multimodal single-cell and spatial analyses reveal a distinct immune ecosystem in pediatric classic Hodgkin lymphoma

Shinichiro Oshima, Yifan Yin, Nawar Dakhallah, Rose Chami, Bo Ngan, Angela Punnett, Hang Yin, Isabella Kong, Shinya Rai, Adele Telenius, Robert Kridel, Federico Gaiti, David Scott, Kara Kelly, Debra Friedman, Sharon Castellino, Lisa Roth, Christian Steidl, Tomohiro Aoki

Blood (2025) 146 (Supplement 1): 3552.

https://doi.org/10.1182/blood-2025-3552

Published: 2025

Journal Articles

National landscape of real-world pediatric blinatumomab care delivery in the United States: A report from the Children's Oncology Group

Blood (2025) 146 (Supplement 1): 1077.

https://doi.org/10.1182/blood-2025-1077

Published: 2025

Journal Articles

Association between COMT activity and development of infections during therapy for pediatric acute lymphoblastic leukemia

Katherine Lee, Jason Stevenson, Anjali Khanna, Ashleigh Hawk, Atese Natalie Akoto, Oyin Alao, Jazmin Huerta, Christopher Porter, Daniel John Bergsagel, Sharon Castellino, Tamara Miller

Blood (2025) 146 (Supplement 1): 2753.

https://doi.org/10.1182/blood-2025-2753

Published: 2025

Journal Articles

Real-world clinical outcomes with novel agent combination therapies for the frontline treatment of pediatric and adult advanced-stage Hodgkin lymphoma

Blood (2025) 146 (Supplement 1): 1852.

https://doi.org/10.1182/blood-2025-1852

Published: 2025

Journal Articles

Interim and end-of-treatment FDG-PET demonstrate limited ability to predict 3-year progression-free survival with nivolumab-AVD in first-line treatment of advanced stage Hodgkin lymphoma: Imaging sub-analysis of Phase 3 S1826 study

Blood (2025) 146 (Supplement 1): 1851.

https://doi.org/10.1182/blood-2025-1851

Published: 2025

Journal Articles

Age-related differences in presentation among pediatric, adolescent, and young adults with mixed cellularity vs. nodular sclerosis histology Hodgkin lymphoma on Children's oncology group treatment and registry trials

Mallorie Heneghan, Lindsay Renfro, Yue Wu, Angela Feraco, Jamie Flerlage, Boyu Hu, Erin Marcotte, Cindy Schwartz, Kara Kelly, Sharon Castellino, Justine Kahn

Blood (2025) 146 (Supplement 1): 1849.

https://doi.org/10.1182/blood-2025-1849

Published: 2025

Journal Articles

Characterizing Hodgkin lymphoma survivors' shared decision making across the care continuum

Raymond Mailhot Vega, M Devyn Mullis, Carla Fisher, Audrey Gardner, Jackie Causer, Ed Michel, Robin Cacchio, Rashad Hayes, Emilie Lynch, Tricia Hernandez, Sharon Castellino, Erin Mobley

Blood (2025) 146 (Supplement 1): 6424.

https://doi.org/10.1182/blood-2025-6424

Published: 2025

Journal Articles

The influence of age on patient-reported outcomes (PROs) endpoints on the S1826 cross-network Phase III trial of advanced-stage, classic Hodgkin lymphoma (cHL)

Kelly Davison, Joseph Unger, Hongli Li, Sharon Castellino, Hildy Dillon, Tricia Hernandez, Sarah Rutherford, Angela Punnett, Michael LeBlanc, Joo Song, Sonali Smith, Andrew Evens, Kara Kelly, Jonathan Friedberg, Alex Herrera, Susan Parsons

Blood (2025) 146 (Supplement 1): 2738.

https://doi.org/10.1182/blood-2025-2738

Published: 2025

Journal Articles

Association of race and ethnicity and incidence and severity of hyperglycemia and clinically-treated hypertension during induction therapy for pediatric acute lymphoblastic leukemia

Jason Stevenson, Anjali Khanna, Ashleigh Hawk, Oyin Alao, Natalie Akoto, Jazmin Huerta, Amy Hunt, Kendall Keebaugh, Sarah Lau, Yoonseo Park, Michael Schwartz, Tyler Vajdic, Xu Ji, Sharon Castellino, Tamara Miller

Blood (2025) 146 (Supplement 1): 2736.

https://doi.org/10.1182/blood-2025-2736

Published: 2025

Journal Articles

Optimizing high-dose methotrexate treatment regimens to improve exposure and mitigate toxicity in infant patients with acute lymphoblastic leukemia

Zachary Taylor, Erin Breese, Kelly Faulk, Shlomit Barzilai-Birenboim, Austin Brown, Eric Schafer, Brooke Bernhardt, Sharon Castellino, Maureen O'Brien, Laura Ramsey, Tamara Miller

Blood (2025) 146 (Supplement 1): 4531.

https://doi.org/10.1182/blood-2025-4531

Published: 2025

Journal Articles

Inotuzumab ozogamacin in refractory or 1st or greater relapse of pediatric B-ALL as bridge to cure: A single center experience

Waitman Aumann, Katherine Lee, Anna Bennett, Stephanie Bernardo, Lois Chukoian, Kathleen Kaspar, Amy Lahey, Kelly MacDonald, Jacqueline Schlesinger, Daniel John Bergsagel, Diana Fridlyand, Frank Keller, Melinda Pauly, Lauren Raney, Himalee Sabnis, Ryan Summers, Sharon Castellino, Tamara Miller

Blood (2025) 146 (Supplement 1): 3351.

https://doi.org/10.1182/blood-2025-3351

Published: 2025

Journal Articles

Changes in body composition during early phases of treatment and subsequent risk of relapse in childhood Hodgkin lymphoma

Aman Wadhwa, Chen Dai, Omar Ahmen, Sandra Kessel, Joshua Richman, Wei Shen, Justine Kahn, Sharon Castellino, Kara Kelly, Debra Friedman, Smita Bhatia

Blood (2025) 146 (Supplement 1): 156.

https://doi.org/10.1182/blood-2025-156

Published: 2025

Journal Articles

Clinical prognostication in the SWOG 1826 randomized clinical trial of nivolumab-AVD versus brentuximab-AVD: Performance of the advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI)

Carla Casulo, Hongli Li, Alex Herrera, Sharon Castellino, Sarah Rutherford, Kelly Davison, Angela Punnett, Brad Kahl, John Leonard, Sonali Smith, Joo Song, Kara Kelly, Jonathan Friedberg, Michael Leblanc, Susan Parsons, Angie Mae Rodday, Andrew Evens

Blood (2025) 146 (Supplement 1): 154.

https://doi.org/10.1182/blood-2025-154

Published: 2025

Journal Articles

3-year follow-up of the S1826 study confirms improved progression-free survival with nivolumab-AVD compared to brentuximab vedotin-AVD in advanced stage classic Hodgkin lymphoma

Blood (2025) 146 (Supplement 1): 151.

https://doi.org/10.1182/blood-2025-151

Published: 2025

Journal Articles

Advancing strategies to improve chemotherapy adherence in young children with ALL: Understanding the role of behavioral parenting skills and daily barriers to identify novel intervention targets

Elizabeth Bouchard, Sharon Castellino, Gregory Fabiano, Karen Lutfey Spencer, Mark Prince, Leonard Epstein, Paula Vincent, Hital Patel, Diana Fridlyand, Susan LaValley, Elisa Rodriguez, Ashton Joseph, Kara Kelly

Blood (2025) 146 (Supplement 1): 6274.

https://doi.org/10.1182/blood-2025-6274

Published: 2025

Journal Articles

Circulating tumor DNA analyses of molecular tumor burden are superior to PET-assessed responses in patients with advanced stage classic Hodgkin lymphoma treated on SWOG S1826

Blood (2025) 146 (Supplement 1): 351.

https://doi.org/10.1182/blood-2025-351

Published: 2025

Journal Articles

Association between adolescent and young adult (AYA) age, acuity of illness at diagnosis, and clinical trial enrollment among patients with hematologic malignancies at a pediatric center

Joshua Muniz, Xu Ji, Tarun Jain, Liberty Strange, Katherine Lee, Rebecca Williamson Lewis, Tamara Miller, Sharon Castellino

Blood (2025) 146 (Supplement 1): 6291.

https://doi.org/10.1182/blood-2025-6291

Published: 2025

Journal Articles

The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort

Sharon Castellino, Shelly Lensing, Caroline Riely, Shesh N. Rai, Rene Davila, Randall T. Hayden, Jackie Fleckenstein, Mark Levstik, Shari Taylor, Patrick J. Dean, Sarah Kippenbrock, Jennifer Pope, Jeanne Carr, Donald K. Strickland, Melissa M. Hudson

Blood (2004) 103 (7): 2460–2466.

https://doi.org/10.1182/blood-2003-07-2565

Published: 2004

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Multimodal single-cell and spatial analyses reveal a distinct immune ecosystem in pediatric classic Hodgkin lymphoma

National landscape of real-world pediatric blinatumomab care delivery in the United States: A report from the Children's Oncology Group

Association between COMT activity and development of infections during therapy for pediatric acute lymphoblastic leukemia

Real-world clinical outcomes with novel agent combination therapies for the frontline treatment of pediatric and adult advanced-stage Hodgkin lymphoma

Interim and end-of-treatment FDG-PET demonstrate limited ability to predict 3-year progression-free survival with nivolumab-AVD in first-line treatment of advanced stage Hodgkin lymphoma: Imaging sub-analysis of Phase 3 S1826 study

Age-related differences in presentation among pediatric, adolescent, and young adults with mixed cellularity vs. nodular sclerosis histology Hodgkin lymphoma on Children's oncology group treatment and registry trials

Characterizing Hodgkin lymphoma survivors' shared decision making across the care continuum

The influence of age on patient-reported outcomes (PROs) endpoints on the S1826 cross-network Phase III trial of advanced-stage, classic Hodgkin lymphoma (cHL)

Association of race and ethnicity and incidence and severity of hyperglycemia and clinically-treated hypertension during induction therapy for pediatric acute lymphoblastic leukemia

Optimizing high-dose methotrexate treatment regimens to improve exposure and mitigate toxicity in infant patients with acute lymphoblastic leukemia

Inotuzumab ozogamacin in refractory or 1st or greater relapse of pediatric B-ALL as bridge to cure: A single center experience

Changes in body composition during early phases of treatment and subsequent risk of relapse in childhood Hodgkin lymphoma

Clinical prognostication in the SWOG 1826 randomized clinical trial of nivolumab-AVD versus brentuximab-AVD: Performance of the advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI)

3-year follow-up of the S1826 study confirms improved progression-free survival with nivolumab-AVD compared to brentuximab vedotin-AVD in advanced stage classic Hodgkin lymphoma

Advancing strategies to improve chemotherapy adherence in young children with ALL: Understanding the role of behavioral parenting skills and daily barriers to identify novel intervention targets

Circulating tumor DNA analyses of molecular tumor burden are superior to PET-assessed responses in patients with advanced stage classic Hodgkin lymphoma treated on SWOG S1826

Association between adolescent and young adult (AYA) age, acuity of illness at diagnosis, and clinical trial enrollment among patients with hematologic malignancies at a pediatric center

The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only